Advanced Oncotherapy plc (LON:AVO – Get Free Report)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1.75 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares traded.
Advanced Oncotherapy Price Performance
The firm has a 50 day simple moving average of GBX 1.75 and a two-hundred day simple moving average of GBX 1.75. The company has a market capitalization of £9.50 million, a PE ratio of -25.00 and a beta of 0.06. The company has a current ratio of 1.26, a quick ratio of 0.13 and a debt-to-equity ratio of 98.71.
About Advanced Oncotherapy
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
See Also
- Five stocks we like better than Advanced Oncotherapy
- How to Use Stock Screeners to Find Stocks
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- How to Use the MarketBeat Excel Dividend Calculator
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
